ATE305510T1 - Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden - Google Patents

Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden

Info

Publication number
ATE305510T1
ATE305510T1 AT98964802T AT98964802T ATE305510T1 AT E305510 T1 ATE305510 T1 AT E305510T1 AT 98964802 T AT98964802 T AT 98964802T AT 98964802 T AT98964802 T AT 98964802T AT E305510 T1 ATE305510 T1 AT E305510T1
Authority
AT
Austria
Prior art keywords
polypeptides
ulbp
isolated
human
cell
Prior art date
Application number
AT98964802T
Other languages
English (en)
Inventor
David John Cosman
Jurgen H Mullberg
William Cristian Fanslow
Marek Kubin
Richard J Armitage
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE305510T1 publication Critical patent/ATE305510T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98964802T 1997-12-17 1998-12-17 Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden ATE305510T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6985797P 1997-12-17 1997-12-17
US9294698P 1998-07-15 1998-07-15
PCT/US1998/027048 WO1999031241A1 (en) 1997-12-17 1998-12-17 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides

Publications (1)

Publication Number Publication Date
ATE305510T1 true ATE305510T1 (de) 2005-10-15

Family

ID=26750491

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964802T ATE305510T1 (de) 1997-12-17 1998-12-17 Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden

Country Status (12)

Country Link
US (7) US6653447B1 (de)
EP (1) EP1037991B1 (de)
JP (1) JP4255211B2 (de)
AT (1) ATE305510T1 (de)
AU (1) AU742757C (de)
CA (1) CA2315251A1 (de)
DE (1) DE69831754T2 (de)
DK (1) DK1037991T3 (de)
ES (1) ES2251120T3 (de)
IL (2) IL136621A0 (de)
NZ (1) NZ505500A (de)
WO (1) WO1999031241A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
KR20020007329A (ko) * 1999-03-15 2002-01-26 다케다 야쿠힌 고교 가부시키가이샤 신규 단백질 및 그의 용도
WO2002062997A1 (fr) * 2001-02-05 2002-08-15 Takeda Chemical Industries, Ltd. Nouvelle proteine et son utilisation
US6821522B2 (en) 2001-05-31 2004-11-23 The Regents Of The University Of California Tumor Therapy
US7364890B2 (en) 2001-07-28 2008-04-29 Midwest Research Institute Thermal tolerant avicelase from Acidothermus cellulolyticus
MXPA04003057A (es) 2001-10-04 2005-06-20 Immunex Corp Proteina 4 de enlace ul16.
WO2003089616A2 (en) * 2002-04-22 2003-10-30 Fred Hutchinson Cancer Research Center Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
WO2004022706A2 (en) * 2002-09-04 2004-03-18 The Trustees Of The University Of Pennsylvania Immune cell receptor ligand and immune cell receptor
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
EP1413316A1 (de) * 2002-09-27 2004-04-28 Bruno Robert Bifunktionelle Konjugate oder Fusionsproteine
BRPI0408774A (pt) * 2003-03-24 2006-03-28 Scripps Research Inst vacinas de dna contra crescimento tumoral e seus usos
US7666417B2 (en) * 2003-04-22 2010-02-23 Fred Hutchinson Cancer Research Center Methods and compositions for treating autoimmune diseases or conditions
GB0403491D0 (en) * 2004-02-17 2004-03-24 Univ Cambridge Tech Polypeptides, methods and means
DE602005015302D1 (en) 2004-04-05 2009-08-20 Univ California Nkg2d modulation
US7998481B2 (en) * 2004-04-05 2011-08-16 The Regents Of The University Of California Modulation of NKG2D for treating or preventing solid organ allograft rejection
US9074013B2 (en) 2004-11-29 2015-07-07 Sequenom, Inc. Means and methods for detecting methylated DNA
AU2005308916B2 (en) 2004-11-29 2011-07-21 Sequenom, Inc. Kits and methods for detecting methylated DNA
EP1909832A4 (de) * 2005-06-29 2010-01-13 Univ Miami Antikörper-immunzell-liganden-fusionsprotein für die krebstherapie
WO2007143245A2 (en) 2006-06-01 2007-12-13 Midwest Research Institute An l-arabinose fermenting yeast
EP2112930B1 (de) 2007-02-21 2017-01-11 Vaccinex, Inc. Modulation der nkt-zellaktivität mit antigenbeladenen cdid-molekülen
US20110038865A1 (en) * 2007-06-26 2011-02-17 University Of Miami Antibody- endostatin fusion protein and its variants
US9611313B2 (en) 2007-06-26 2017-04-04 University Of Miami Antibody-endostatin fusion protein and its variants
US8070021B2 (en) * 2007-10-31 2011-12-06 Momentive Performance Materials Hydraulic container evacuator and method
NZ593794A (en) 2009-01-08 2013-04-26 Einstein Coll Med Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
EP2556086B1 (de) 2010-04-09 2015-03-04 Amgen Inc. Btnl9-proteine, nukleinsäuren sowie antikörper und ihre verwendung
US9593347B2 (en) 2010-04-16 2017-03-14 University of Pittsburgh—of the Commonwealth System of Higher Education Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors
WO2012064743A2 (en) 2010-11-08 2012-05-18 The Johns Hopkins University Methods for improving heart function
WO2013036799A2 (en) * 2011-09-09 2013-03-14 Fred Hutchinson Cancer Research Center Methods and compositions involving nkg2d inhibitors and cancer
US10093705B2 (en) 2011-09-13 2018-10-09 Dana-Farber Cancer Institute, Inc. Compositions and methods for brown fat induction and activity using FNDC5
US20130156808A1 (en) * 2011-11-22 2013-06-20 Stipan Jonjic Vaccine comprising beta-herpesvirus
EP2875046B1 (de) 2012-07-19 2020-02-26 Amgen Inc. Humane btnl3-proteine, nukleinsäuren sowie antikörper und verwendungen davon
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
WO2014144817A2 (en) 2013-03-15 2014-09-18 Amgen Inc. Inhibitory polypeptides specific to wnt inhibitors
WO2015017529A2 (en) 2013-07-31 2015-02-05 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating thermogenesis using pth-related and egf-related molecules
US11427627B2 (en) 2013-09-05 2022-08-30 Amgen Inc. Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
ES2781852T3 (es) 2013-10-28 2020-09-08 Univ Pittsburgh Commonwealth Sys Higher Education Vector de HSV oncolítico
CA2935804A1 (en) 2014-01-14 2015-07-23 Dana-Farber Cancer Institute, Inc. Compositions and methods for identification, assessment, prevention, and treatment of melanoma using pd-l1 isoforms
MX2016014761A (es) 2014-05-16 2017-05-25 Amgen Inc Ensayo para detectar poblaciones celulares linfocitos t colaboradores 1 (th1) y linfocitos t colaboradores (th2).
HUE058851T2 (hu) 2014-12-05 2022-09-28 Xyphos Biosciences Inc Inzertálható variábilis antitestfragmentumok és az NKG2D ligandumok módosított A1-A2 doménjei
US11117969B2 (en) * 2014-12-05 2021-09-14 Xyphos Biosciences Inc. Insertable variable fragments of antibodies and modified α1-α2 domains of NKG2D ligands
EP3368157B1 (de) 2015-10-29 2022-06-29 Dana-Farber Cancer Institute, Inc. Verfahren zur identifizierung, beurteilung, prävention und behandlung von stoffwechselerkrankungen mit verwendung von pm20d1 und n-lipidierten aminosäuren
EP4089166A1 (de) 2016-01-27 2022-11-16 Oncorus, Inc. Oncolytische virale vektoren und verwendungen davon
WO2017218689A1 (en) 2016-06-14 2017-12-21 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Expression of nkg2d activating ligand proteins for sensitizing cancer cells to attack by cytotoxic immune cells
SG11201811600PA (en) 2016-06-30 2019-01-30 Oncorus Inc Pseudotyped oncolytic viral delivery of therapeutic polypeptides
JP2020501595A (ja) 2016-12-21 2020-01-23 クリエイタス バイオサイエンシス インコーポレイテッド キシリトールを生産するメチニコビア種
BR112019013007A2 (pt) 2016-12-21 2019-10-08 Creatus Biosciences Inc organismo microbiano não natural, método de produção de um composto bioderivado, composto bioderivado e composição
MA47775A (fr) 2017-03-14 2020-01-22 Amgen Inc Contrôle des glycoformes afucosylées totales d'anticorps produits en culture cellulaire
RU2771110C2 (ru) 2017-07-26 2022-04-26 Онкорус, Инк. Онколитические вирусные векторы и их применение
WO2019133847A1 (en) 2017-12-29 2019-07-04 Oncorus, Inc. Oncolytic viral delivery of therapeutic polypeptides
MA52186A (fr) 2018-03-26 2021-02-17 Amgen Inc Glycoformes afucosylées totales d'anticorps produits en culture cellulaire
WO2020051013A2 (en) * 2018-08-24 2020-03-12 The Trustees Of Columbia University In The City Of New York Anti-cd33 and nkg2d ligand chimeras for treatment of myeloid malignancies
US20220349898A1 (en) 2019-09-26 2022-11-03 Amgen Inc. Methods of producing antibody compositions
EP4162257A1 (de) 2020-06-04 2023-04-12 Amgen Inc. Beurteilung von reinigungsvorgängen eines biotherapeutischen herstellungsverfahrens
KR20230087539A (ko) 2020-10-15 2023-06-16 암젠 인크 항체 생산 방법에서의 상대적인 비결합 글리칸
CA3222409A1 (en) 2021-06-07 2022-12-15 Amgen Inc. Using fucosidase to control afucosylation level of glycosylated proteins
WO2023059607A1 (en) 2021-10-05 2023-04-13 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023158732A1 (en) 2022-02-16 2023-08-24 Dana-Farber Cancer Institute, Inc. Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
USRE38824E1 (en) * 1986-08-04 2005-10-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antibodies against human herpes virus-6(HHV-6) and method of use
US5834229A (en) * 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5474771A (en) * 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
US5464771A (en) * 1994-04-29 1995-11-07 The United States Of America As Represented By The Secretary Of Agriculture Biologically pure culture of Actinomyces viscosus strain used for the bioremediation of chlorinated hydrocarbons
EP0904381A2 (de) * 1996-04-05 1999-03-31 Kieta Holding S.A. Zusammensetzungen und methode zur auffindung von arzneimitteln gegen, sowie zur detektion und behandlung von gastrointestinalen krankheiten
US5912415A (en) * 1996-05-16 1999-06-15 Regents Of The University Of Minnesota Arabidopsis spindly gene, methods of identification and use
US20030060407A1 (en) * 1997-06-16 2003-03-27 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
JP4255211B2 (ja) 2009-04-15
US20090324597A1 (en) 2009-12-31
AU742757C (en) 2007-05-17
US7427669B2 (en) 2008-09-23
US20080008715A1 (en) 2008-01-10
US20110281789A1 (en) 2011-11-17
AU742757B2 (en) 2002-01-10
US6774224B2 (en) 2004-08-10
DK1037991T3 (da) 2006-01-09
US6653447B1 (en) 2003-11-25
JP2002508183A (ja) 2002-03-19
US8410252B2 (en) 2013-04-02
EP1037991A1 (de) 2000-09-27
US7807796B2 (en) 2010-10-05
AU2004599A (en) 1999-07-05
US20040235058A1 (en) 2004-11-25
US6458350B1 (en) 2002-10-01
US20030147847A1 (en) 2003-08-07
IL136621A0 (en) 2001-06-14
NZ505500A (en) 2002-12-20
CA2315251A1 (en) 1999-06-24
DE69831754D1 (de) 2006-02-09
WO1999031241A1 (en) 1999-06-24
US7193058B2 (en) 2007-03-20
ES2251120T3 (es) 2006-04-16
EP1037991B1 (de) 2005-09-28
IL136621A (en) 2008-07-08
DE69831754T2 (de) 2006-06-29

Similar Documents

Publication Publication Date Title
ATE305510T1 (de) Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden
ATE362534T2 (de) Menschliche tslp nukleinsäuren und polypeptide
ATE301195T1 (de) Acpl dna und polypeptide
ES2080809T3 (es) Receptores de factor de necrosis tumoral alfa y beta.
HK1039624A1 (en) Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
WO1998030694A3 (en) TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
DE69331501D1 (de) Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
EP0833948A4 (de) Für den dickdarm spezifische gene und proteine
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
DE60031414D1 (de) Einkettige polypeptide enthaltend n-terminale troponin i fragmente und troponin c
CA2251262A1 (en) Nucleic acid encoding a nervous tissue sodium channel
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
ATE332373T1 (de) Menschlisches il-1 epsilon dna und polypeptide
WO1999031256A3 (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
MX9709455A (es) Polinucleotidos de adenosina-cinasa.
EP1690871A3 (de) Xrec2 DNS und Polypeptide
RU93029440A (ru) Фрагмент днк нс280, полипептид, штаммы бактерий escherichia coli - продуценты полипептидов
NZ528704A (en) Novel PRO717 polypeptides and nucleic acids encoding a 12 transmembrane polypeptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037991

Country of ref document: EP

REN Ceased due to non-payment of the annual fee